JP2004155791A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004155791A5 JP2004155791A5 JP2004000542A JP2004000542A JP2004155791A5 JP 2004155791 A5 JP2004155791 A5 JP 2004155791A5 JP 2004000542 A JP2004000542 A JP 2004000542A JP 2004000542 A JP2004000542 A JP 2004000542A JP 2004155791 A5 JP2004155791 A5 JP 2004155791A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- metformin
- hypoglycemic agent
- acting hypoglycemic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 239000003472 antidiabetic agent Substances 0.000 claims 2
- 229940126904 hypoglycaemic agent Drugs 0.000 claims 2
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical group CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 claims 2
- 229960003105 metformin Drugs 0.000 claims 2
- FAEKWTJYAYMJKF-QHCPKHFHSA-N GlucoNorm Chemical compound C1=C(C(O)=O)C(OCC)=CC(CC(=O)N[C@@H](CC(C)C)C=2C(=CC=CC=2)N2CCCCC2)=C1 FAEKWTJYAYMJKF-QHCPKHFHSA-N 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N phenylalanine group Chemical group N[C@@H](CC1=CC=CC=C1)C(=O)O COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 1
- 229960002354 repaglinide Drugs 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK69497 | 1997-06-13 | ||
| US6336897P | 1997-10-29 | 1997-10-29 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP50135099A Division JP2002500677A (ja) | 1997-06-13 | 1998-06-12 | 新規ｎｉｄｄｍ療法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004155791A JP2004155791A (ja) | 2004-06-03 |
| JP2004155791A5 true JP2004155791A5 (enExample) | 2005-09-15 |
Family
ID=26064473
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP50135099A Withdrawn JP2002500677A (ja) | 1997-06-13 | 1998-06-12 | 新規ｎｉｄｄｍ療法 |
| JP2004000542A Withdrawn JP2004155791A (ja) | 1997-06-13 | 2004-01-05 | 新規ｎｉｄｄｍ療法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP50135099A Withdrawn JP2002500677A (ja) | 1997-06-13 | 1998-06-12 | 新規ｎｉｄｄｍ療法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6677358B1 (enExample) |
| EP (2) | EP1011673B1 (enExample) |
| JP (2) | JP2002500677A (enExample) |
| AT (1) | ATE201139T1 (enExample) |
| AU (1) | AU7906898A (enExample) |
| DE (1) | DE69800806T2 (enExample) |
| DK (1) | DK1011673T3 (enExample) |
| ES (1) | ES2159184T3 (enExample) |
| GR (1) | GR3036078T3 (enExample) |
| PT (1) | PT1011673E (enExample) |
| WO (1) | WO1998056378A1 (enExample) |
| ZA (1) | ZA985126B (enExample) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4175662B2 (ja) | 1996-01-08 | 2008-11-05 | インパルス ダイナミクス エヌ．ヴイ． | 電気的筋肉制御装置 |
| US9289618B1 (en) | 1996-01-08 | 2016-03-22 | Impulse Dynamics Nv | Electrical muscle controller |
| US9713723B2 (en) | 1996-01-11 | 2017-07-25 | Impulse Dynamics Nv | Signal delivery through the right ventricular septum |
| US7006871B1 (en) | 1997-07-16 | 2006-02-28 | Metacure N.V. | Blood glucose level control |
| US20040081697A1 (en) * | 1998-11-12 | 2004-04-29 | Smithkline Beecham P.L.C. | Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent |
| US20030153607A1 (en) * | 1998-11-12 | 2003-08-14 | Smithkline Beecham P.L.C. | Novel composition and use |
| US20040102486A1 (en) * | 1998-11-12 | 2004-05-27 | Smithkline Beecham Corporation | Novel method of treatment |
| US6958324B2 (en) | 1998-12-02 | 2005-10-25 | Inotek Pharmaceuticals Corporation | Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease |
| US9101765B2 (en) | 1999-03-05 | 2015-08-11 | Metacure Limited | Non-immediate effects of therapy |
| US6559188B1 (en) | 1999-09-17 | 2003-05-06 | Novartis Ag | Method of treating metabolic disorders especially diabetes, or a disease or condition associated with diabetes |
| US6878749B2 (en) | 1999-09-17 | 2005-04-12 | Novartis Ag | Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes |
| CO5200844A1 (es) * | 1999-09-17 | 2002-09-27 | Novartis Ag | Una combinacion que comprende nateglinida y cuando por menos otro compuesto antidiabetico usada para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con dibetes |
| ITMI20002019A1 (it) * | 1999-09-17 | 2002-03-15 | Novartis Ag | Metodo per il trattemento dei disturbi metabolici, in particolare diabete oppure una malattia oppure una condizione associate con il diabete |
| US6586438B2 (en) * | 1999-11-03 | 2003-07-01 | Bristol-Myers Squibb Co. | Antidiabetic formulation and method |
| AU2007201729B2 (en) * | 1999-12-23 | 2010-02-25 | Novartis Ag | Use of hypoglycemic agent for treating impaired glucose metabolism |
| HUP0600522A2 (en) | 1999-12-23 | 2006-11-28 | Novartis Ag | Use of hypoglycemic agent for treating impaired glucose metabolism |
| EP1616561B1 (en) | 1999-12-28 | 2008-06-25 | Ajinomoto Co., Inc. | Antidiabetic preparation for oral administration |
| WO2001052860A2 (en) * | 2000-01-24 | 2001-07-26 | Inotek Corporation | Method and composition for modulating an immune response |
| BR0108043A (pt) * | 2000-02-01 | 2003-04-01 | Stevia Aps | Substância para uso em complementação de dieta ou para preparação de um medicamento para o tratamento de diabetes melito não-dependente de insulina, hipertensão e/ou sìndrome metabólica |
| CA2403442A1 (en) * | 2000-03-17 | 2002-09-17 | Ajinomoto Co., Inc. | Use of nateglinide alone or in combination for the treatment or prevention of diabetic complications |
| US7964216B2 (en) | 2001-01-12 | 2011-06-21 | Sun Pharma Advanced Research Company Limited | Spaced drug delivery system |
| US7956041B2 (en) | 2002-04-26 | 2011-06-07 | Ajinomoto Co., Inc. | Prophylactic and therapeutic agent of diabetes mellitus |
| CA2484306A1 (en) * | 2002-04-26 | 2003-11-06 | Katsumi Maezono | Prophylactic and therapeutic agent of diabetes mellitus |
| PL376577A1 (pl) | 2002-06-17 | 2006-01-09 | Themis Laboratories Private Limited | Wielowarstwowe tabletki zawierające tiazolidinedion i biguanidy oraz metody ich wytwarzania |
| US6830759B2 (en) | 2002-06-28 | 2004-12-14 | Ajinomoto Co., Inc. | Antidiabetic preparation for oral administration |
| US11439815B2 (en) | 2003-03-10 | 2022-09-13 | Impulse Dynamics Nv | Protein activity modification |
| US9931503B2 (en) | 2003-03-10 | 2018-04-03 | Impulse Dynamics Nv | Protein activity modification |
| US11779768B2 (en) | 2004-03-10 | 2023-10-10 | Impulse Dynamics Nv | Protein activity modification |
| EP1898991B1 (en) | 2005-05-04 | 2016-06-29 | Impulse Dynamics NV | Protein activity modification |
| WO2007131930A1 (en) * | 2006-05-13 | 2007-11-22 | Novo Nordisk A/S | Tablet formulation comprising repaglinide and metformin |
| WO2008037807A1 (en) * | 2006-09-29 | 2008-04-03 | Novo Nordisk A/S | Pharmaceutical formulation comprising metformin and repaglinide |
| CN101756971B (zh) * | 2008-10-09 | 2013-09-18 | 北京德众万全药物技术开发有限公司 | 一种盐酸二甲双胍瑞格列奈的口服固体药物组合物 |
| US8934975B2 (en) | 2010-02-01 | 2015-01-13 | Metacure Limited | Gastrointestinal electrical therapy |
| WO2014102715A1 (en) | 2012-12-24 | 2014-07-03 | Ranbaxy Laboratories Limited | Pharmaceutical compositions comprising a biguanide and a low dose antidiabetic agent |
| WO2014184742A1 (en) | 2013-05-13 | 2014-11-20 | Ranbaxy Laboratories Limited | Pharmaceutical compositions containing a biguanide and a low dose antidiabetic agent |
| WO2018034627A1 (en) | 2016-08-18 | 2018-02-22 | İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi | Pharmaceutical composition of antidiabetic tablet |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2118040A (en) * | 1982-02-15 | 1983-10-26 | Hoechst Uk Ltd | Oral anti-diabetic preparation |
| SG43036A1 (en) | 1991-06-21 | 1997-10-17 | Thomae Gmbh Dr K | (S) (+) -2-ethoxy-4-[N-[1-(2-piperidino-phenyl)-3-methyl- 1-buthyl]aminocarbony methyl] - benzoic a cid |
-
1998
- 1998-06-12 ES ES98929228T patent/ES2159184T3/es not_active Expired - Lifetime
- 1998-06-12 EP EP98929228A patent/EP1011673B1/en not_active Revoked
- 1998-06-12 WO PCT/DK1998/000248 patent/WO1998056378A1/en not_active Ceased
- 1998-06-12 ZA ZA985126A patent/ZA985126B/xx unknown
- 1998-06-12 AT AT98929228T patent/ATE201139T1/de not_active IP Right Cessation
- 1998-06-12 JP JP50135099A patent/JP2002500677A/ja not_active Withdrawn
- 1998-06-12 AU AU79068/98A patent/AU7906898A/en not_active Abandoned
- 1998-06-12 DE DE69800806T patent/DE69800806T2/de not_active Revoked
- 1998-06-12 EP EP01100320.9A patent/EP1097710B1/en not_active Expired - Lifetime
- 1998-06-12 PT PT79102124T patent/PT1011673E/pt unknown
- 1998-06-12 DK DK98929228T patent/DK1011673T3/da active
-
1999
- 1999-12-13 US US09/459,526 patent/US6677358B1/en not_active Expired - Lifetime
-
2001
- 2001-06-19 GR GR20010400923T patent/GR3036078T3/el not_active IP Right Cessation
-
2004
- 2004-01-05 JP JP2004000542A patent/JP2004155791A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR028299A1 (es) | Una composicion farmaceutica que comprende nateglinida, un proceso para su preparacion y el uso de dicha composicion para la preparacion de un medicamento para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con diabetes. | |
| WO2007090091A3 (en) | Drug delivery systems comprising weakly basic drugs and organic acids | |
| CL2008000823A1 (es) | Formulacion farmaceutica de liberacion inmediata que comprende dapagliflozina propilenglicol hidrato y un portador farmaceuticamente aceptable; uso para tratar diabetes, intolerancia a la glucosa, resistencia a la insulina, entre otras. | |
| JP2005512995A5 (enExample) | ||
| IL236426B (en) | Use of a compound in combination with bortezomib to prepare a drug for a neoplastic disease and a pharmaceutical preparation containing a compound and bortezomib | |
| WO2004100857A3 (en) | Highly plastic granules for making fast melting tablets | |
| JP2005512997A5 (enExample) | ||
| BRPI0309544B8 (pt) | preparação farmacêutica oral estável ao armazenamento compreendendo oxicodona e naloxona | |
| JP2007529532A5 (enExample) | ||
| DE60310039D1 (de) | Pharmazeutische tablette | |
| SI1578422T1 (sl) | Fizikalno in kemiäśno stabilni nikotin in mikrokristal na celulozo vsebujoäś material iz trdnih delcev | |
| EP1787640A4 (en) | GRAINED PHARMACEUTICAL COMPOSITION WITH TEMPORARY DELIVERY FOR ORAL ADMINISTRATION AND FAST-DECREASING INTRAORAL TABLET WITH THE COMPOSITION | |
| NZ521799A (en) | Sustained release paracetamol composition | |
| HUP0004966A3 (en) | Pharmaceutical composition for oral administration in the form of matrix tablet enabling the prolonged release of trimetazidine | |
| IL181150A0 (en) | Pharmaceutical composition in the form of a gastric-resident tablet containing an active principle | |
| JP2012533559A5 (enExample) | ||
| JP2008515980A5 (enExample) | ||
| JP2009516719A5 (enExample) | ||
| ATE373488T1 (de) | Antimykobakterielle pharmazeutische zusammensetzung mit einem arzneimittel gegen tuberkulose | |
| JP2006342148A5 (enExample) | ||
| MY140413A (en) | Saquinavir mesylate oral dosage form | |
| JP2006527741A5 (enExample) | ||
| JP2006516279A5 (enExample) | ||
| GB0624498D0 (en) | Pharmaceutical compositon containing a stable and clear solution of anti-inflammatory drug in soft gelatin capsule and process for producing the same | |
| CO5170463A1 (es) | Formas polimorfas de un citrato de azobiciclo [2,2,2]octan- 3-amina y sus composiciones farmaceuticas |